Association of SRD5A2 variants and serum androstane-3alpha,17beta-diol glucuronide concentration in Chinese elderly men.

BACKGROUND Results of recent studies have demonstrated that genetic variants of the enzyme steroid 5α reductase type II (SRD5A2) are associated with serum concentrations of major androgen metabolites such as conjugates of androstane-3α,17β-diol-glucuronide (3α-diol-G). However, this association was not consistently found among different ethnic groups. Thus, we aimed to determine whether the association with SRD5A2 genetic variations exists in a cohort of healthy Chinese elderly men, by examining 2 metabolite conjugates: androstane-3α,l7β-diol-3-glucuronide (3α-diol-3G) and androstane-3α,17β-diol-17-glucuronide (3α-diol-17G). METHODS We used GC-MS and LC-MS to measure serum sex steroid concentrations, including testosterone and dihydrotestosterone, and 3α-diol-3G and 3α-diol-17G in 1182 Chinese elderly men age 65 and older. Genotyping of the 3 SRD5A2 tagSNPs [rs3731586, rs12470143, and rs523349 (V89L)] was performed by using melting-temperature-shift allele-specific PCR. RESULTS The well-described SRD5A2 missense variant rs523349 (V89L) was modestly associated with the 3α-diol-17G concentration (P = 0.040). On the other hand, SNP rs12470143 was found to be significantly correlated with 3α-diol-3G concentration (P = 0.021). Results of haplotype analysis suggested that the presence of an A-C-G haplotype leads to an increased 3α-diol-3G concentration, a finding consistent with results of single SNP analysis. CONCLUSIONS The genetic variation of SRD5A2 is associated with circulating 3α-diol-3G and 3α-diol-17G concentrations in Chinese elderly men. In addition, we showed that SRD5A2 haplotypic association, rather than a single SNP alone, might be a better predictor of the 3α-diol-G concentration. Thus, the effect of either the haplotype itself or of other ungenotyped SNPs in linkage disequilibrium with the haplotype is responsible for the interindividual variation of 3α-diol-G.

[1]  J. Woo,et al.  Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[2]  A. Singleton,et al.  Genomewide association studies and human disease. , 2009, The New England journal of medicine.

[3]  M. Thun,et al.  Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). , 2009, Human molecular genetics.

[4]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[5]  E. Demerath,et al.  Meta-analysis of genome-wide association data identifies two loci influencing age at menarche , 2009, Nature Genetics.

[6]  S. Cummings,et al.  Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. , 2009, The Journal of clinical endocrinology and metabolism.

[7]  B. Yeap Testosterone and ill-health in aging men , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[8]  L. Lönn,et al.  Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  D. Posthuma,et al.  Heritability of reproductive hormones in adult male twins. , 2007, Human reproduction.

[10]  D. English,et al.  5α‐Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia , 2007, International journal of cancer.

[11]  S. Olson,et al.  Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. , 2007, American journal of epidemiology.

[12]  Claes Ohlsson,et al.  Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  D. English,et al.  Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[14]  Karen Chuang,et al.  High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. , 2005, BioTechniques.

[15]  D. Carmelli,et al.  Heritability of plasma sex hormones and hormone binding globulin in adult male twins. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  R. Altman,et al.  Finding haplotype tagging SNPs by use of principal components analysis. , 2004, American journal of human genetics.

[17]  B. Horne,et al.  Principal component analysis for selection of optimal SNP‐sets that capture intragenic genetic variation , 2004, Genetic epidemiology.

[18]  Z. Meng,et al.  Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. , 2003, American journal of human genetics.

[19]  T. Key,et al.  Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  T. Habuchi,et al.  Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. , 2003, The Journal of urology.

[21]  J. Reichardt,et al.  Hormones and prostate cancer: Current perspectives and future directions , 2002, The Prostate.

[22]  F. Mostofi,et al.  Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[24]  M. Forrest,et al.  The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  C. J. Chen,et al.  Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. , 2000, Journal of the National Cancer Institute.

[26]  R Higuchi,et al.  Single-tube genotyping without oligonucleotide probes. , 1999, Genome research.

[27]  M. Pike,et al.  A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. , 1997, Cancer research.

[28]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.